Aurobindo Pharma Limited, Unit VII – 2/10/2026. 1/27/2023. Country: India. Record Type: 483
Similar Posts
Lunds & Byerlys Voluntary Recalls L&B Monster Cookies Due to Incorrect Labeling
EDINA, Minn., December 9, 2025 – Lunds & Byerlys is voluntarily recalling its L&B Monster Cookies as the wrong ingredient label was applied to the packaging. Packages may contain undeclared peanuts, egg, and soy. People who have allergies to peanuts, egg, and soy run theHealth Fraud Scams
Learn how to spot health fraud and avoid it.BRS Analytical Services, LLC – 711133 – 09/17/2025
CGMP/Finished Pharmaceuticals/AdulteratedSCA Pharmaceuticals Inc. Little Rock, AR. 483 issued 10/30/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 10/30/2025
Short Title (70 char) SCA Pharmaceuticals Inc. Little Rock, AR. 483 issued 10/30/2025
FEI Number 3010683157
Firm Name SCA Pharmaceuticals Inc
Record Type 483
State AR
Establishment Type Outsourcing FaOTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2025 User Fees and Registration – 05/20/2025
OTC Monograph Drug User Fee Program (OMUFA); Understanding FY 2025 User Fees and RegistrationPatient-Focused Drug Development: Workshop #2 to Discuss Methodologic and Other Challenges Related to Patient Experience Data – 09/18/2025
On September 18 and 19, 2025, the U.S. Food and Drug Administration (FDA) is hosting a virtual public workshop to discuss methodological challenges related to patient experience data encountered, including the submission and evaluation of patient experience data in the context of the benefit-risk assessment and product labeling, as well as other ar